GleamWall
中文EN

MTEX MANNATECH INC

Medicinal Chemicals & Botanical Products · Nasdaq · SEC CIK 1056358 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-6.6%
TTM net income YoY74.3%
TTM EPS YoY64.0%
Revenue 3-yr CAGR-8.3%
Net income 3-yr CAGR—

Margins

Gross margin75.7%
Operating margin0.9%
Net margin-0.4%
FCF margin-0.6%
EBITDA margin1.9%

Returns

ROE-7.0%
ROA-1.4%
ROIC (approx.)17.8%
Asset turnover3.33x

Leverage & solvency

Liabilities / assets81.3%
Debt / equity0.53x
Current ratio1.18x
Interest coverage2.00x

Cash quality & payout

Operating cash flow / net income0.48x
Accruals ratio-0.7%
Payout ratio—
Capex / revenue0.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$24.87M$26.65M$24.92M$26.64M$29.16M$25.68M$26.56M$29.01M
Cost of revenue$6.29M$6.16M$6.06M$6.58M$6.89M$6.78M$6.83M$5.64M
Gross profit$18.58M$20.49M$18.86M$20.05M$22.27M$18.90M$19.74M$23.36M
SG&A expense$8.70M$8.98M$9.28M$9.79M$9.07M$10.78M$10.02M$10.43M
Operating income$272,000$998,000-$180,000-$157,000$2.01M-$1.44M-$833,000$864,000
Interest expense$119,000$117,000$104,000$127,000$104,000$102,000$73,000$83,000
Pretax income-$1.95M$1.17M$1.11M$210,000$2.51M-$4.29M-$1.32M$2.88M
Income tax-$10.86M$150,000$161,000$11.51M$590,000$23,000$206,000$614,000
Net income$8.90M$1.01M$950,000-$11.29M$1.92M-$4.31M-$1.53M$2.26M
EBITDA$518,000$1.26M$81,000$103,000$2.27M-$1.17M-$540,000$1.22M
EPS (basic)4.610.530.49—1.01-2.27-0.80—
EPS (diluted)4.610.530.49—1.01-2.27-0.80—
Weighted avg. shares (diluted)1.93M1.93M1.93M—1.90M1.90M1.90M—
Banking
Net interest income——————-$73,000-$83,000
Balance sheet
Cash & equivalents$5.42M$6.03M$7.01M$6.18M$7.14M—$9.32M$11.40M
Receivables$1,000$137,000$10,000$1,000$38,000—$102,000$19,000
Inventory$9.57M$9.59M$9.67M$10.12M$11.13M—$11.82M$10.40M
Current assets$19.79M$19.41M$21.20M$20.58M$22.09M—$26.55M$26.12M
PP&E, net$2.64M$2.75M—$3.14M$3.23M——$2.71M
Intangibles$237,000$237,000$237,000$237,000$237,000——$237,000
Total assets$27.90M$27.47M$29.88M$29.99M$33.92M—$36.67M$36.06M
Current liabilities$16.80M$16.86M$19.47M$18.73M$19.50M—$22.58M$20.90M
Long-term debt$2.75M$2.75M$2.75M$2.75M$2.90M———
Total debt$2.75M$2.75M$2.75M$2.75M$2.90M———
Total liabilities$22.70M$32.44M$35.44M$35.22M$26.97M—$29.08M$27.44M
Shareholders' equity$5.20M-$4.97M-$5.55M-$5.22M$6.95M$5.96M$7.58M$8.61M
Net debt-$2.67M-$3.28M-$4.26M-$3.44M-$4.24M———
Shares outstanding1.93M1.93M1.93M1.90M1.90M—1.90M1.88M
Cash flow statement
Operating cash flow-$249,000-$792,000$1.13M-$289,000$2.41M-$3.72M-$1.37M-$219,000
Capital expenditure$131,000$10,000$129,000$174,000$548,000$142,000$489,000-$106,000
Free cash flow-$380,000-$802,000$997,000-$463,000$1.86M-$3.86M-$1.86M-$113,000
Investing cash flow-$131,000-$10,000-$129,000-$174,000-$548,000-$142,000-$489,000$118,000
Financing cash flow-$148,000$228,000-$126,000-$242,000-$73,000-$80,000-$166,000-$905,000
Depreciation & amortization$246,000$259,000$261,000$260,000$261,000$278,000$293,000$360,000
Stock-based compensation$26,000$54,000$274,000$32,000$38,000$158,000$263,000$22,000
Dividends paid———————$0
Share buybacks———————$0

Free plan shows the latest 8 periods; Pro shows all 73 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.